GlassScriptPhysician profile
Jacob Lee
NPI 1205151875
$14,425.98
in general payments reported to CMS, 2019-2025
45 companies · $2,508 in 2025
The $2,508 reported for 2025 was more than what 82% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,709 · 2020: $1,287 · 2021: $1,633 · 2022: $1,153 · 2023: $2,210 · 2024: $3,924 · 2025: $2,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,536 · Consulting Fee: $2,859 · Travel and Lodging: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,536.46 |
| Consulting Fee | $2,859.38 |
| Travel and Lodging | $247.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,996.98 | 2019-2025 | Proclaim, Eterna, Exclaim |
| Medtronic, INC. | $1,170.08 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Nevro Corp. | $1,075.01 | 2019-2024 | Senza |
| Boston Scientific Corporation | $989.18 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Intracept |
| Collegium Pharmaceutical, INC. | $979.02 | 2019-2025 | Xtampza, Belbuca |
| Relievant Medsystems, INC. | $671.21 | 2023 | Intracept |
| Medtronic USA, INC. | $488.71 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $362.17 | 2019-2021 | |
| Globus Medical, INC. | $271.62 | 2025 | Senza |
| Mml US, INC. | $267.13 | 2023-2025 | Reactiv8 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $237.61 | 2019-2025 | Relistor |
| Tersera Therapeutics LLC | $218.43 | 2019-2025 | Prialt |
| Averitas Pharma INC. | $162.27 | 2023-2025 | Qutenza |
| Nalu Medical, INC. | $141.73 | 2022-2023 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $112.43 | 2024-2025 | Prospera |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.